Background and Purpose: The goal of this study was to determine the alterations in vascular reactivity of human basilar artery after subarachnoid hemorrhage.
C erebral arterial vasospasm is a major cause of morbidity and mortality in patients with subarachnoid hemorrhage (SAH) after rupture of an intracranial aneurysm. Despite intensive research, the basic pathogenesis of the vasospasm remains unclear. Several substances in the cerebrospinal fluid have been implicated in its etiology: catecholamines, 1 5-hydroxytryptamine, 2 prostaglandins, 34 fibrin-fibrinogen degradation products, 5 oxyhemoglobin, 6 ' 7 and neuropeptide Y. 8 Furthermore, an imbalance in prostacyclin and thromboxane A 2 production in the cerebral arterial wall, 910 the potent vasoconstrictor effect of endothelin, which is released by the vascular endothelium, 1112 increased contraction due to denervation supersensitivity 13 - 14 or the development of proliferative vasculopathy 15 may be involved in the pathogenesis of cerebral vasospasm. Thus, the pathogenesis of the delayed spasm appears to be multifactorial. An intact vascular endothelium has been shown to play an obligatory role in producing relaxation via endothelium-derived relaxing factor (EDRF) in response to a number of agonists. 16 - 17 Recently, decreased endothelium-dependent relaxation in response to sev-
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eral agonists after SAH has been reported to be involved in delayed cerebral vasospasm. 18 - 21 However, to our knowledge, brain vessels examined by the isometric tension recording method were limited to those obtained from experimental animal models of SAH. Therefore, it is not clear whether the results from experimental animal models are applicable to preparations from subjects who died after SAH.
The aim of the present study was to elucidate whether vascular responses to several agonists, especially in relation to endothelium-dependent relaxation, would change in basilar arteries isolated from subjects who died after SAH.
Materials and Methods
Basilar arteries were carefully removed from subjects who died within 1 day after SAH (SAH group) and those who died from causes other than brain involvement (control group) during autopsy 2-10 hours after death. Although all subjects in both groups had been admitted to an emergency hospital, all were dead on arrival and thus were not given clinical treatment. The profiles of SAH and control groups are summarized in Table 1 . For all subjects of the SAH group, autopsy revealed diffuse SAH, most prominently around the brain stem region with blood in the Sylvian fissures and basal cisterns, and clotted blood covering the circle of Willis and the posterior cerebral, basilar, and vertebral arteries.
The basilar arteries obtained were immediately placed in a petri dish containing fresh Krebs-Ringer solution and freed of blood clots and pieces of arachnoid membrane under magnification. The cleaned artery was divided into two segments for measurement of isometric tension and for histological study. To measure isometric tension, they were cut into two to three spiral strips approximately 2 mm wide and 15 mm long. The strips were fixed vertically between hooks in a 10-ml organ bath containing Krebs-Ringer solution maintained at 37 C C and aerated with a gas mixture of 95% O 2 and 5% CO 2 , which had a pH of 7.4. The Krebs-Ringer solution had a millimolar composition of 118 NaCl, 4.7 KC1, 2. Isometric tension was monitored with a force-displacement transducer (Nihon Kohden Kogyo Co., Tokyo, Japan) to which the upper end of the strip was connected, as previously reported, 22 and was recorded with a pen recorder (Nihon Kohden Kogyo). The strips were equilibrated for approximately 2 hours, during which time the organ bath medium was replaced every 15 minutes, and the hooks were then adjusted to give a resting tension of 1.5 g. The contraction experiment was conducted with samples from case No. 1 to No. 6 of the control group and No. 7 to No. 11 of the SAH group ( Table 1 ). The endothelium was removed from one strip each of the six cases of the control group by rubbing the intimal surface with filter paper. 16 Successful removal of endothelial cells from aortic strips was confirmed by the inability of 10" 5 M bradykinin, an endothelium-dependent vasodilator, 23 to induce relaxation, and by histological examination of the intimal surface, using a silver staining technique. 24 In both groups, KC1 (10-60 mM), norepinephrine (10~9-10~5 M), and 5-hydroxytryptamine (10~9-10~5 M) were cumulatively added to the organ bath. Contraction by KC1 was expressed as milligrams tension/milligrams tissue weight and that by norepinephrine and 5-hydroxytryptamine was expressed as a percentage of the contraction elicited by 60 mM KC1. (Table 1) . Strips from both groups were subjected to precontraction with 10" 6 M phenylephrine, and then bradykinin (10~9-10~5 M), calcium ionophore A23187 (10~8-10~6 M), and sodium nitroprusside (10~9-10~6 M) were cumulatively added to the organ bath. However, for the thrombin experiment, application of 5 National Institutes of Health (NIH) units/ml was done only once to each strip, because the relaxation by thrombin resulted in tachyphylaxis toward a second exposure, which prevented data collection for a dose-response curve. 23 In a separate experiment, one strip from each subject in the SAH group was exposed to 10" 5 M indomethacin for 60 minutes before the addition of phenylephrine. The vascular responses to thrombin and bradykinin in the presence of indomethacin were compared with those induced by each agonist in its absence using another strip from the same subject. Relaxation was expressed as a percentage of contraction in response to 10" 6 M phenylephrine. The drugs were added to the organ bath medium in a volume of 50-100 /xl, and their final concentrations in the medium are given in the text.
Morphometric study was carried out on a paraffinembedded section using the other segment from the basilar artery. Cross sections were cut at approximately 1-mm intervals to obtain five arterial sections. The sections were stained with van Gieson's elastica stain, and morphometric determination was performed with an image analyzer system (Quantimet 720, Cambridge Instrument, Cambridge, England) to evaluate the area of the intima and media and the length of the internal elastic lamina, as previously described. 25 - 26 The intimal index, an index of intimal thickening, was calculated by dividing the area of the intima by the area enclosed by the internal elastic lamina (internal elastic lamina area) in its theoretically unwrinkled state, according to the following formula 27 -28 : (intimal area/corrected internal elastic lamina area) x 100. The corrected internal elastic lamina area was calculated from the formula (length of internal elastic lamina) 2 /4ir, where internal elastic lamina is the length of the lamina in millimeters. Each measurement was performed for the five sections obtained from one segment, and the mean value was calculated to avoid site differences.
Bradykinin was purchased from Peptide Institute Inc., Osaka, Japan. Bovine thrombin (1,280 NIH units/mg) was obtained from Mochida Pharmaceutical Co., Ltd., Tokyo, Japan. 1-Norepinephrine hydrochloride, 1-phenylephrine hydrochloride, 5-hydroxytryptamine, calcium ionophore A23187, and sodium nitroprusside were all obtained from Sigma Chemical Co., St. Louis, Mo.
The data are expressed as mean±SEM. The concentrations needed to reach 50% maximal contraction (ED 50 values) and relaxation (ID 50 values) were determined graphically after linear regression of the 20-80% region of the log concentration-response curves (norepinephrine, 10~8-5xl0~7 M; 5-hydroxytryptamine, 10"
8 -5xl0-7 M; bradykinin, 3xl0-9 -3xl0" 7 M). Student's unpaired t test was used for statistical comparisons of two groups. Comparison of values obtained in the SAH group before and after treatment with indomethacin was performed by the paired / test. The level of significance was p<0.05. Table 1 , the mean value of age in the SAH group was not different from that in the control group in both contraction and relaxation experiments. Table 2 shows the mean values of intimal and medial area and also the intimal index for the control and SAH groups. In both contraction and relaxation experiments, no significant differences were found in any of these values between the two groups.
Results

As shown in
Dose-response curves for KC1-, norepinephrine-, and 5 -hydroxytryptamine-induced contractions did not show significant differences between the control and SAH groups (Figure 1) . The contractile response to norepinephrine or 5-hydroxytryptamine did not show significant differences in vascular strips with and without endothelium in the control group (Table 3) . Endothelium-dependent relaxation in response to thrombin (5 units/ml) was significantly less in the SAH group than in the control group (Figure 2) . Also, the endotheliumdependent relaxations in response to bradykinin and A23187 were significantly less at almost all concentrations tested for the SAH group than for the control group (Figures 2 and 3) . However, the dose-response curve for the endothelium-independent relaxation in response to sodium nitroprusside was comparable in the two groups (Figure 3 ). The relaxation response to 5 units/ml thrombin and the dose-response curve of bradykinin in the SAH group did not significantly differ whether indomethacin was present or absent (the respective data are as follows: for thrombin, 8.1 ±5.1% and 8.6±4.3%,n=7; for bradykinin, ID 50 , 9.3±1.9xl0" 
Discussion
In the present study, the contractile response to KC1, norepinephrine, and 5-hydroxytryptamine did not show any significant difference between the control and SAH groups. This result suggests that the ability of the artery to produce a contractile response to these agonists in the SAH group, at least functionally, was well preserved. In experimental animal models of SAH, the contractile response has been observed to increase because of denervation supersensitivity 13 -14 caused by the presence of blood clots in the subarachnoid space. In contrast, reduction in the contractile responses due to a functional or structural derangement of contractile elements of smooth muscle cells has also been reported. 29 - 30 However, our result, which showed no change in the contractile response, is not necessarily inconsistent with these reports that the changes (i.e., increase or decrease) in contractile response occur after SAH, because the arteries used in the above studies 1314 -2930 had been obtained 2-7 days after SAH, whereas in our study they had been obtained within 1 day. Thus, the lapse of time after SAH may be an important factor causing change in the contractile response to vasoactive substances. In a previous study, the cerebrospinal fluids collected from patients with SAH produced greater contractions of normal human basilar arteries than those from patients without SAH because of their higher concentrations of 5-hydroxytryptamine. 31 Thus, although the contraction in response to 5-hydroxytryptamine did not increase following SAH in the present study, we cannot exclude the role of 5-hydroxytryptamine as a spasmogen, because of its higher concentration.
Recently, delayed vasospasm has been thought to be related to an impairment of endothelium-dependent relaxation. 18 " 21 In a previous study with human basilar arteries, the endothelium-dependent relaxations induced by thrombin, bradykinin, and calcium ionophore A23187 were inhibited by methylene blue (a guanylate cyclase inhibitor) and bromophenacyl bromide (an inhibitor of EDRF-mediated relaxation) but not by indomethacin (a cyclooxygenase inhibitor). 23 Thus, the three vasodilators share a common susceptibility to these inhibitors, suggesting that these vasodilators can produce relaxation via a similar EDRF-like substance(s). In the present study, endothelium-dependent relaxation in response to thrombin and bradykinin was significantly depressed in the SAH group compared with the control group. However, the endothelium-independent relaxation in response to sodium nitroprusside, which, like EDRF, activates soluble guanylate cyclase in smooth muscle cells and produces relaxation, did not differ between the two groups. Also, the increase in the amount of medial smooth muscle after SAH may result in a relative shortage of the EDRF-like substance to cause relaxation, and thereby may lead to the decreased relaxation. However, this is an unlikely explanation because there was no difference in the area of medial smooth muscle between the two groups. Therefore, decreased relaxation probably occurs at the level of the endothelium and not smooth muscle cells. The decreased relaxation in the SAH group may be due to one or more of the following factors. First, intimal thickening of arterial wall has been observed after SAH. 3233 Therefore, disturbances in the transport of the EDRF-like substance to smooth muscle cells and accelerated destruction of this substance may play a role in the decrease of relaxation. However, this possibility is unlikely because the intimal area and intimal index in morphometric analysis of intimal thickening did not show any significant difference between the two groups. A second possibility is that vasoconstrictor substances, such as prostaglandins 34 and endothelin, 11 ' 12 are involved in delayed vasospasm after SAH. These substances, which may be released together with EDRF in response to agonists, may inhibit endothelium-dependent relaxation. However, as the relaxation response to thrombin and bradykinin in the SAH group was not affected by indomethacin, cyclooxygenase products such as prostaglandin F 2a do not appear to be involved in the decreased relaxation, although the involvement of endothelin cannot be ruled out. A third possibility is that an inflammatory process occurs in the arterial wall after SAH. 34 Inflammatory cells such as macrophages can release oxygen radicals that destroy EDRF. 35 -36 Thus, accelerated destruction of an EDRF-like substance may be a mechanism contributing to impaired vasorelaxation. The most plausible explanation is that loss of the relaxation results from a decrease in the ability of the endothelium to produce and/or liberate an EDRF-like substance. A decrease in relaxation is not likely to occur at the level of receptors on endothelial cells, because the relaxation response to calcium ionophore A23187, which causes endothelium-dependent relaxation in a manner unrelated to any receptor mechanism, led to decreased relaxation in the SAH group. Such ultrastructural changes as the appearance of vacuoles and dense bodies in endothelial cells, 3738 which are observed as early as 2 hours after SAH, may be responsible for the decreased production and/or release of an EDRF-like substance.
In the experimental model with rabbit basilar arteries, norepinephrine and 5-hydroxytryptamine produced greater contractions after SAH; the basilar arteries also showed a decrease in endothelium-dependent relaxations. 19 Thus, a decrease in endothelium-dependent relaxations after SAH may raise the possibility that norepinephrine and 5-hydroxytryptamine result in greater contraction in the SAH group than in the control group. However, in our study, these agonists did not produce greater contractions after SAH. The reason for this difference may be as follows. In normal rabbit basilar artery, the contraction in response to norepinephrine and 5-hydroxytryptamine was found to be greater in endothelium-denuded arteries than in endothelium-intact arteries. 39 However, in normal canine 39 and human basilar arteries obtained from the control group, the contraction to them did not differ in the two types of strips. Thus, in contrast to rabbit basilar arteries, vasodilator substance(s) in amounts sufficient to significantly counteract the contractile response may not be released from endothelial cells of normal canine and human basilar arteries. For this reason, even if endothelium is damaged or endothelium-dependent relaxation is impaired, the contraction in response to these agonists may not be potentiated after SAH.
In contrast to the comparable contractile forces in the two groups, endothelium-dependent relaxation was decreased in the SAH group. This result suggests that the endothelium is functionally impaired at an earlier stage than in smooth muscle cells. The decreased relaxation may be responsible for delayed cerebral spasm, as previously reported. 18~21 However, an important point to note is that decreased endothelium-dependent relaxation in experimental animal models has been observed 2-8 days after SAH, 18 -21 during which the delayed spasm becomes most commonly apparent, but in our study the decreased relaxation was observed in preparations obtained within 1 day after SAH. Therefore, the fact that the decrease in the relaxation response was observed in a period in which delayed spasm does not occur raises the question of whether the decreased relaxation plays a causative role in the spasm. In the present study, the degree of bleeding in the SAH subjects was so severe that they are likely to have died a short time after rupture of the aneurysm. Thus, our SAH cases obtained at medicolegal autopsy may be different from usual clinical treatment cases in which there is survival until delayed spasm occurs. The severity of bleeding may explain the difference in time during which decreased relaxation is observed between experimental animal models and the present study. Therefore, time difference does not necessarily mean that a decrease in endothelium-dependent relaxation is not associated with delayed vasospasm. However, further work is needed to clarify this. Another possibility is that decreased endothelium-dependent relaxation may occur as early as 1 day after SAH even in clinical cases in which delayed spasm is observed. If this is true, how a decrease in the relaxation leads to delayed spasm remains unknown.
In conclusion, the decreased endothelium-dependent relaxations in response to thrombin and bradykinin that are generated during blood coagulation were demonstrated to occur in preparations obtained from subjects who died after SAH, although the decreased response was observed at an earlier stage in our SAH cases than in experimental animal models of SAH.
Editorial Comment
Mechanisms that account for vasospasm after subarachnoid hemorrhage are controversial and may be multifactorial. 1 One mechanism that may contribute to vasospasm is inhibition of endothelium-dependent mechanisms that normally influence cerebral vascular tone. Under basal conditions and in response to specific stimuli, blood vessels release endothelium-derived relaxing factor (EDRF), which inhibits vascular tone by activating guanylate cyclase and increasing cyclic guanosine 5'-monophosphate (GMP) levels in smooth muscle. 2 Inhibition of production or activity of EDRF contracts cerebral arteries under resting conditions and impairs relaxation in response to endothelium-dependent agonists. 34 Endothelium-dependent relaxation is impaired in experimental models of subarachnoid hemorrhage. 5 -9 The mechanism that produces this impairment may involve decreased production of EDRF or decreased formation of cyclic GMP in vascular muscle in response to EDRF.
In this issue of Stroke, Hatake et al provide the first evidence that subarachnoid hemorrhage is associated
